Levetiracetam G.L.

Levetiracetam, the active ingredient in Levetiracetam G.L., is an anticonvulsant presented as an oral tablet for systemic use. It is prescribed to manage various seizure types in patients with epilepsy.

GNH USA supplies Levetiracetam G.L. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide, ensuring consistent quality and regulatory compliance across markets. Our distribution network adheres to stringent quality standards to meet the needs of healthcare providers globally.

Levetiracetam is an antiepileptic drug used to control seizures across several epilepsy syndromes.

- Partial‑onset seizures: Reduces the frequency of focal seizures in patients with epilepsy. - Myoclonic seizures: Decreases the occurrence of sudden, brief muscle jerks. - Primary generalized tonic‑clonic seizures: Helps prevent loss of consciousness and convulsive episodes. - Epilepsy (overall): Provides broad seizure control as part of a comprehensive treatment plan.

Levetiracetam is generally well tolerated, but a range of adverse reactions has been reported.

Common Side Effects: - Dizziness: Transient sensation of light‑headedness. - Fatigue: Persistent tiredness affecting daily activities. - Somnolence: Increased sleepiness, especially after dose initiation. - Headache: Mild to moderate cranial pain. - Irritability: Mood changes or increased agitation. - Nausea: Gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe allergic reactions: Rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: Rare but serious skin disorder. - Suicidal thoughts: Emergence of depressive or suicidal ideation. - Severe skin rash: Including toxic epidermal necrolysis. - Blood disorders: Thrombocytopenia or leukopenia. - Multi‑organ hypersensitivity: Systemic inflammatory response.

When prescribing levetiracetam, clinicians should consider several safety aspects.

- Renal impairment: Adjust dose according to renal function. - Hepatic impairment: Monitor liver enzymes and adjust therapy if needed. - Pregnancy: Discuss potential risks and benefits with the patient. - Psychiatric symptoms: Observe for mood changes, depression, or aggression. - Concomitant CNS depressants: Use with caution to avoid excessive sedation. - Store at ambient temperature: Keep in the original container, protect from moisture and heat.

Levetiracetam may interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: Can lower levetiracetam plasma concentrations. - Phenobarbital: May reduce levetiracetam levels. - Phenytoin: Potential reduction of levetiracetam exposure. - Rifampin: Induces metabolism, decreasing levetiracetam effectiveness.

Moderate Interactions (Monitor Closely): - Valproic acid: May increase levetiracetam concentrations. - Alcohol: Can enhance central nervous system depression. - Other antiepileptics: Monitor overall seizure control and side‑effect profile.